Jason Deng

Company: WuXi AppTec

Job title: Senior Director, DEL Biology & Screen

Seminars:

WuXi AppTec’s DEL Technology for DIscovering Peptides with Improved Stability & Cell Permeability 10:00 am

Peptide therapeutics are emerging as viable treatments for traditionally difficult-to-drug targets, though discovery methods like phage and mRNA display face limitations such as low stability and poor cell penetration. WuXi AppTec's DEL technology overcomes these issues by enabling the integration of unnatural amino acids into vast peptide libraries, thereby improving their stability and cell permeability.…Read more

day: Conference Day 1